Evan A. Thackaberry
Corporate Officer/Principal at VIGIL NEUROSCIENCE, INC.
Net worth: 4 770 $ as of 31/05/2024
Evan A. Thackaberry active positions
Companies | Position | Start | End |
---|---|---|---|
VIGIL NEUROSCIENCE, INC. | Corporate Officer/Principal | 01/09/2020 | - |
Career history of Evan A. Thackaberry
Former positions of Evan A. Thackaberry
Companies | Position | Start | End |
---|---|---|---|
RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2017 | 01/03/2020 |
Training of Evan A. Thackaberry
University of Wisconsin | Doctorate Degree |
Statistics
International
United States | 4 |
Operational
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
VIGIL NEUROSCIENCE, INC. | Health Technology |
Private companies | 1 |
---|---|
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Evan A. Thackaberry
- Experience